proprioceptive signals going back, transmitting information about the prior state of the locomotor 18 system and its changes, e.g., in limb position. 19
Disturbances in proprioception in PD is a central factor in the development of the motor symptoms in 20 PD (Dietz, 2002; Konczak et al., 2009 ). PD patients are, for instance, worse compared to healthy 21 controls (HC) at detecting passive movements of their limbs which is dependent on proprioceptive 22 afferents ( Boyle, 2000) . The apparent deterioration in the utilization of proprioceptive 24 information in PD does not appear to be caused by disturbances in the PNS. Recordings of muscle 25 spindle responses by microneurography show no differences in afferent signals between HC and PD 26 patients (Mano, Yamazaki, & Mitarai, 1979) . The early cortical processing of proprioceptive signals-27 measured with electroencephalography (EEG) as the event-related potentials (ERPs) following passive 28 movements of the index fingers-does not differ between PD patients and HC (Seiss, Praamstra, 29 Hesse, & Rickards, 2003) . The disturbances in proprioception in PD thus appear to arise in the higher levels of sensorimotor 38 integration. Impaired utilization of proprioceptive information in PD patients also shows when 39 switching from visually guided to the proprioceptive guided control of balance (Bronstein, Hood, 40 Gresty, & Panagi, 1990) . Errors in integrating proprioceptive signals are seen in grasping tasks where 41 PD patients show increased grip force when grasping objects compared to HC, suggesting that 42 proprioceptive feedback and active motor commands are not adequately integrated to facilitate optimal 43 grasping (Fellows, Noth, & Schwarz, 1998; Nowak & Hermsdörfer, 2006) . Impaired proprioception 44 degrades sensorimotor integration, which is compensated with feedback from other sensory domains 45 (Abbruzzese & Berardelli, 2003; Konczak et al., 2009) . 46
Disturbances in the proprioceptive processing in PD appears to be due to errors in the integration of 47 proprioceptive afferents, but the actual mechanisms of the disturbances in the processing of 48 proprioceptive signals are unknown. If loss of proprioception in PD is due to disturbed communication 49 between the basal ganglia, thalamus, and cortical motor areas, due to a faulty integration of 50 proprioceptive signals later at a later processing stage, or outside the dopamine-dependent pathways 51
has not yet been adequately explained (Rabin et al., 2010) . Isolating the relative contribution from 52 efferent and afferent signals on movement control to answer how afferents are affected in PD is 53 difficult, as both are necessary for successfully carrying out the movements and depends on functional 54 and anatomical overlapping neural processes (Prud'homme & Kalaska, 1994). In the present study, we 55 investigate how the contribution from afferent proprioceptive afferents are processed in PD in the 56 absence of efferent motor signals by stimulating only the proprioceptive afferents in passive 57 movements. 58 PD is associated with changes in neural oscillatory behavior demonstrated both at local and global 59 levels. Local field potentials from the subthalamic nucleus (STN) in PD patients show an increase in The decrease of beta-band oscillations in STN due dopaminergic medication have been correlated to 64 an overall reduction in motor symptoms in PD (Kühn, Kupsch, Schneider, & Brown, 2006 ). The level of synchronicity of cortical beta activity is related to rigidity and action tremor in PD 71 (Airaksinen et al., 2012) . 72
Cortical beta-band oscillations are actively involved in sensorimotor processing. Beta-band 73 oscillations exhibit well-known event-related desynchronization (ERD) and event-related 74 synchronization (ERS) during active states of the sensorimotor system ( Fig. 1 ). Beta oscillations 75 attenuate in the second before movement onset, known as the movement-related ERD, and is prevalent 76 during the duration of the movement (Cheyne, 2013 Salmelin & Hari, 1994) . Once the movement 78 stops, the beta oscillations temporarily show a relative increase, known as the post-movement ERS or 79 beta rebound, before going settling back at the baseline level. (Cheyne, 2013; Kilavik et al., 2013; 80 Neuper & Pfurtscheller, 1996; Pfurtscheller, Stancák, & Neuper, 1996; Salmelin & Hari, 1994) . The 81 origin of both the movement-related beta ERD and the beta rebound during voluntary movements is 82 the primary somatosensory cortex (Druschky et al., 2003; Xiang et al., 1997) with the cortical source 83 of the movement-related being more posterior than the source of subsequent beta rebound (Jurkiewicz 84 et al., 2006) . 85 86
Figure 1: Movement-related beta-band activity. Typical event-related synchronization (ERS) and desynchronization (ERD)
87 in the beta-band during movements measured from the cortex with EEG/MEG. When initiating a movement beta activity start 88 to desynchronize and prevails as a persistent ERD during the movement execution phase. Once the movement ends, it is 89 followed by an ERS referred to as the beta rebound.
90
The movement-related ERD and beta rebound seen during voluntary movements is attenuated in PD 91 compared to HC. PD patients show less beta ERD before and during active movements and a smaller 92 rebound after active movements (Devos et al., 2003 ; Heinrichs-Graham, Wilson, et al., 2014; 93 Pfurtscheller, Pichler-Zalaudek, Ortmayr, Diez, & Reisecker, 1998). It is currently unclear if the 94 attenuated dynamics in the beta-band in PD is driven by deficits in efferent processes, processes of 95 6 afferents, or at a higher level in the integration of afferent and efferent signals, as both efferent and 96 afferent signals, and the integration of the two, is needed for carrying out voluntary movements. The 97 movement-related ERD is taken to reflect the active state of the motor system, receiving the afferent 98 signals, and the cortical processes responsible for integrating the efferent and afferent signals (Engel & 99 Fries, 2010) . 100
The beta rebound has been linked to proprioceptive afferents. The beta rebound is present for passive 101 induced movements in healthy subjects (Alegre et al., 2002; Parkkonen, Laaksonen, Piitulainen, 102 Parkkonen, & Forss, 2015) meaning the beta rebound is related to the processing of proprioceptive 103 signals independent of the efferent commands from cortex to the periphery. The beta rebound is also 104 diminished when applying a temporary ischemic nerve block to disrupt the proprioceptive feedback 105 from the muscles in healthy subjects (Cassim et al., 2001) . We hypothesize that the attenuated beta 106 ERD and rebound during voluntary movement in PD to some extent related to disturbances in the 107 cortical processing of proprioceptive signals-even though the relative contribution of efferent signals, 108 afferent signals, and the integration is unclear. 109
In the present study, we investigate the differences between PD patients compared to HC regarding the 110 cortical processing of proprioceptive information. In contrast to earlier studies that have used 111 voluntary movements to study beta-oscillations in PD, we isolate the processing of afferent from that 112 of efferent information by using a computer-controlled proprioceptive stimulator that generates precise 113 passive movements of the index finger. With this method, we examine the processing of 114 proprioceptive signals in isolation, without the confounding effect of efferent motor signals. If the 115 attenuation of movement-related ERD and rebound during active movements is due to defect in the 116 processing of proprioceptive afferents in PD, we expect the movement-related ERD and beta rebound 117 to be less salient for PD patients than for HC. Conversely, if the difference between PD and HC 118 primarily depends upon deficits in efferent signaling processing, then we expect there to be no 119 differences between PD and HC during passive movements. We furthermore investigated how 120
Levodopa influences processing of proprioceptive information in PD patients, by examining PD 121 patients both in ON and OFF Levodopa states. While Levodopa improves motor symptoms in PD, it is 122 unclear to what extent it affects proprioceptive processing, as results from behavioral studies have 123 been inconclusive with regards to improvement of proprioceptive function due to medication 124 The continuous data from both sessions were concatenated for each subject, and independent 211 component analysis (ICA) was then performed on the combined data using the fastica algorithm 212 (Hyvarinen, 1999) implemented in MNE-Python (Gramfort et al., 2013) . Components related to eye-213 blinks and heartbeats were identified by selecting components correlating with peaks of the measured 214 EOG and ECG and removed from the raw MEG data. The ICA cleaned continuous MEG data was 215 chopped into epochs from 1.5 s before movement onset to 3.5 s after movement. We rejected trials 216 with extreme jump-artifacts based on min-to-max peak range exceeding 10 pT for the magnetometer 217 and exceeded 2000 fT/cm for gradiometers. 218
The accelerometer data was filtered with a band-pass filter between 1-195 Hz, before averaging the To constrain the analysis and accommodate individual differences in the position of the head inside 264 the MEG helmet that otherwise would have reduced statistical sensitivity, we focused the statistical 265 comparison on the combined gradiometer-pair that showed the highest amplitude in the time interval 266 from 50 ms to 110 ms after stimulation onset. We averaged all trials across conditions per subject, 267 after applying a 90 Hz low-pass filter and combine each orthogonal gradiometer pairs by taking the 268 root of the squared values. The combined gradiometer-pair that showed the highest mean value across 269 the specified time-interval in the phase-locked domain was taken to represent the sensory-motor 270 response to the optimal proprioceptive stimulation. The peak channel was used for the statistical 271 analysis of the induced time-frequency beta-band responses to proprioceptive stimulation.
12
We extracted the time-frequency response from the selected channel in the frequencies within the 273 "mu" spectrum from 8 to 30 Hz, which encompasses the beta (14-30 Hz) and alpha (8-13 Hz) sensory 274 motor rhythms. Comparisons of beta and mu response were combined in a single analysis due to the 275 harmonic component of the mu rhythm, which leaks into the beta-band range (Hari, 2006) . 276
The first effect we tested was for a general change in the beta-band response in PD compared to HC. 277
We compared the OFF-state for PD patients to the first session for HC to get between-group 278 comparison without additional variation introduced by medication. 279
The time-frequency representation of the data was log transformed and the average log-transformed 280 power in a baseline-window from 1.25 s to 0.2 s before stimulation onset was subtracted per frequency 281 bin from the log-transformed time-frequency data. The baseline corrected log-transformed time-282 frequency representation was compared between groups using a cluster-based permutations test (Maris 283 & Oostenveld, 2007) . This method for inferential statistics identifies clusters of adjacent time-284 frequency points along either the time or frequency domains that differ in a point-wise t-test 285 comparison. The t-values of all points in each cluster were summed, and the sum was compared to a 286 distribution of summed cluster values drawn from the same test in which data had been randomly 287 sampled assigned groups using Monte Carlo simulation (n=1000). Clusters which total sum greater 288 than 95% of the sum permutated clusters are considered a significant difference between groups. 289
The second effect we investigated was the effect of Levodopa medication on the beta-band response to 290 the proprioceptive stimulation. To accommodate the effect of repetition upon the effect of medication, 291
we tested the effect of medication in PD patients with a pseudo two-by-two design. The test-retest 292 effect would be present for both the patient group and the HC group, but any medication specific 293 effect would only be present in the patient group since they were the only group who did take any 294 medication. The interaction effect between group and session would regress out the retest effect and 295 represent the effect of the medication. 296
The comparison was made by subtracting the log-transformed time-frequency responses from the first 297 and second session for each subject. The time-frequency difference was then baseline corrected by 298 subtracting the average of the difference in a baseline from 1.25 s to 0.2 s before stimulation onset. 299
Finally, we tested for differences between the groups on the Time-Frequency representation (TFR) 300 differences with a cluster-based permutation test with 1000 random permutations, where clusters 301 beyond the critical alpha (alpha=0.05, two-tailed) of the permutation distribution were considered 302 significant. 303
Baseline beta oscillations 304
The amount of movement-related beta-band ERS and ERD in the beta-band may depend on the 305 spectral power in the beta-band within the baseline period leading up to the movements (Heinrichs-306
Graham & Wilson, 2016; Shin, Law, Tsutsui, Moore, & Jones, 2017). We tested for a relationship 307 13 between the absolute power spectral density in the time-window from 1.25 s to 0.2 s before the passive 308 movements were initiated and the relative change within clusters that showed significant differences in 309 the primary analysis. 310
We tested for a relationship between baseline power and relative power change due to proprioceptive 311 stimulation by fitting a linear regression model that explained the mean spectra power change within OFF medication status, MoCA, HADS depression and anxiety subscales), and the comparison 321 between the two groups. PD patients and HC did not differ in the male/female ratio (BF=0.42), nor in 322 cognitive ability measured by MoCA (BF=0.30), and anxiety score on HADS (BF=0.52). There was a 323 trend in favor of a difference on HADS depression score (BF=1.23), with PD patients scoring higher 324 than HC, and that HC on average was older than PD patients (BF=2.02). None of these trends are 325 sufficient to conclude clear differences between PD patients and HC (Wetzels et al., 2011) . PD 326 patients showed an improvement of motor symptoms after taking medication reflected by the 327 difference in MDS-UPDRS-III score between ON and OFF states (BF=4.30*10 4 ). 328
The number of trials used in the analysis of cortical responses to the proprioceptive stimulation after 329 data cleaning ranged between 66-90 trials with a median of 87 trials. Comparison of the number of 330 useful trials after data cleaning in a "Bayesian ANOVA" (Rouder et al., 2012) showed there were no 331 differences between session (BF H1/H0 =0.33), between groups (BF H1/H0 =0.45) or in the interactions 332 between session and group (BF H1/H0 =0.062). 333
Peripheral muscle activation 334
None of the permutation tests on the EMG time-series showed significant differences between groups 335 (first session: p=0.80, second session: p=0.84) or between sessions (p=0.12 for PD patients and p=0.68 336 for HC). None of the subjects showed time-locked muscle activation to the passive finger movements, 337 confirming that no efferent signals occurred. The time-frequency responses to the proprioceptive stimulation in the beta and mu band showed a 340 significant difference between PD patients OFF medication and HC. The significant difference was 341 defined by a single cluster located 1.0 s after stimulation onset, lasting 0.5 s, covering a frequency 342 range from 14 Hz to 25 Hz (p=0.017). The cluster corresponds to the post-movement beta rebound, 343 which was considerably attenuated, almost absent, in PD patients compared to HC (Fig. 3) . 344
The between-groups and between-sessions comparisons of the effect of levodopa on the beta/mu 345 response to the proprioceptive stimulation yielded no significant result (p=0.45). In the present study, we aimed at elucidating the processing of afferent proprioceptive information in 362 PD by combining two different approaches. First, we used a computer-controlled proprioceptive 363 stimulator that generates precisely controlled passive proprioceptive stimulation, with the aim of 364 separating the processing of afferent proprioceptive information from that of efferent motor 365 information. The controlled proprioceptive stimulation made sure the movements were identical for 366 PD patients and HC in both sessions. Second, we studied PD patients ON and OFF Levodopa 367 medication as compared to HC, with the aim of separating disease-related from medication-related 368 effects. Our results show that when passive movements are used to generate proprioceptive 369 stimulation, there is a definite difference in the cortical processing of afferent proprioceptive signals 370 between PD patients and HC, manifested as a significant reduction-almost absence-of the beta 371 rebound in PD patients as compared to HC (see Fig. 3 ). Our results also show that the beta rebound 372 attenuation was not modulated by medication in PD, despite an evident effect from medication on 373 overt motor symptoms, as assessed with MDS-UPDRS-III. The beta band attenuation hence emerges 374 as a disease-related rather than medication-related change in the processing of afferent proprioceptive 375 information in PD. Since medication does not modulate the attenuation, our results indicate that the 376 disease-related change in proprioceptive processing does not directly reflect the dopaminergic 377 networks of the brain. 378
Relation between beta rebound and baseline beta power
The different stages in the cortical beta response to movements reflect different aspects in the 379 processing of motor commands and proprioceptive feedback (Salmelin & Hari, 1994) . The beta ERD, 380 observed before and during movements (see Fig. 1 ), is taken to reflect a state of heightened sensitivity 381 to efferent and afferent information within the motor system (Jenkinson & Brown, 2011) . This notion 382 has been supported by studies showing that reaction times to stimuli is negatively correlated with beta-383 band power, indicating that motor commands are executed more readily during an ERD when beta-384 band power is decreased (Heinrichs-Graham & Wilson, 2016; Shin et al., 2017) . Such heightened 385 sensitivity facilitates events such as motor commands being carried out efficiently as well as the 386 integration of proprioceptive feedback while carrying out movements. The role of the beta rebound has 387 been suggested to function an effective inhibition of motor responses 388 Salmelin, Hämäläinen, Kajola, & Hari, 1995) . As such the increase of beta oscillation during the beta 389 rebound might reflect a "resetting" of the sensory-motor system, in terms of integrating the 390 proprioceptive feedback from the action into the body schemata, thereby constructing an updated 391 model of the position of the body and the limbs (Engel & Fries, 2010) . The successful update of the 392 body schemata is crucial for the calibration and execution of future actions as they will be dependent 393 on the state of the body schemata to generate future motor commands and efferent signals. 394
The reduced beta rebound response in PD following proprioceptive stimulation might be understood 395 as a deterioration in the processing and integration of proprioceptive singles: where errors in 396 16 integrating proprioceptive signals lead to errors in the internal representation of body-state, and to 397 more imprecise efferent motor commands. The reduction of the beta rebound in PD appears not just to 398 be an after-effect of reduced beta ERS during active movements but related to the distinct processing 399 of proprioceptive afferents. 400
Although the overt motor symptoms in PD patients changed upon Levodopa medication as compared 401 to an initial OFF state (as rated by MDS-UPDRS-III), the attenuation of the beta rebound in PD 402 patients did not change between Levodopa medication states. That we did not see any effect of 403 medication on the beta band response to proprioceptive stimulation is in line with behavioral studies 404 which showed that the error in detecting proprioceptive feedback for PD patients is not affected by 405
Levodopa medication (Jacobs & Horak, 2006) . Indeed, it has even been shown that Levodopa might 406 worsen detection of proprioceptive feedback (Mongeon, Blanchet, & Messier, 2009 ; O'Suilleabhain, 407
Bullard, & Dewey, 2001). Together with the behavioral findings, the finding that Levodopa 408 medication did not alter the cortical responses to proprioceptive feedback results suggests that the 409 dopaminergic system does not primarily mediate the later stages in the processing of proprioceptive 410 signals. As an alternative, it has been proposed that processing of proprioceptive information in PD 411 might rely less on the dopamine-dependent loop between basal ganglia, thalamus, and cortex, and 412 instead involve pathways from the thalamus, through cerebellum to cortical areas (Wu & Hallett, 413 2013). Since MEG primarily detects activity from synchronous populations of pyramidal neurons in 414 the cortex, we can, however, only speculate about the sub-cortical pathways responsible for 415 propagating proprioceptive signals. 416
We acknowledge that it is possible that there might be effects of medication that we do not have 417 sufficient statistical power to pick up due to our sample size. If there is a missed effect of Levodopa on 418 the cortical processing of proprioceptive signals, these effects appear to be smaller than the difference 419 in the beta-rebound response observed between PD patients and HC. Hence, even before we elucidate 420 the post-movement beta rebound and its underlying mechanisms, this finding offers a potential marker 421 for assessing the loss of proprioceptive function PD and disease progression in PD. The fact that the 422 reduction of the beta rebound in the PD patients did not respond to levodopa medication suggest that it 423 represents a reliable, disease-related measure that distinguishes PD patients from HC. Due to the 424 relatively small sample size of PD patients in our current study, we cannot make a decisive conclusion 425 about specific motor symptoms in PD. More studies with larger sample sizes are needed to better 426 understand the role of the beta rebound-both in the general processing of sensory-motor signals and 427 why it is attenuated in PD-and how the attenuation of the beta rebound is related to motor symptoms 428 in PD. 429
Nevertheless, we can conclude is that at the cortical level, there appears to be a deficit in the 430 processing of proprioceptive signals at the later cortical stage of processing and appears to be little 431 affected by Levodopa medication. 432 
